RGD Reference Report - [In vivo effect of annexin I down-regulation on the growth of human pancreatic cancer in nude mice] - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

[In vivo effect of annexin I down-regulation on the growth of human pancreatic cancer in nude mice]

Authors: Liu, Q  Hu, H  Ran, YL  Wang, CF  Zhao, DB  Tian, YT  Sun, LX  Xie, YB  Yang, ZH  Zhao, P 
Citation: Liu Q, etal., Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):897-900.
RGD ID: 2325722
Pubmed: PMID:19173988   (View Abstract at PubMed)

OBJECTIVE: To further explore the effect of annexin I on the tumor growth of human pancreatic cancer in nude mice. METHODS: To knock down the expression of annexin I in pancreatic carcinoma cells by RNAi. A nude mouse model of human pancreatic cancer was established by subcutaneous inoculation of human pancreatic cancer cell line Suit-II cells. The effect of annexin I on tumor growth was assessed by tumor growth curve and tumor weight records, and Westen blot and flow cytometry were used to examine the expression of annexin I after annexin I-knocking down. RESULTS: The results of Western blot revealed that the expression of annexin I was significantly decreased in Suit-II cells transfected with pSilencer-annexin I-siRNA1, and almost completely inhibited in the cells transfected with pSilencer-annexin I-siRNA2 and pSilencer-annexin I-siRNA3. The growth of tumors transfected with annexin I-siRNA2 and annexin I-siRNA3 was inhibited by 76.6% and 68.4%, respectively, in comparison with that of tumor from the parent Suit-II cells. At 44 days after tumor cell inoculation, the tumor weight was 0.8987 g (transfected with annexin I-siRNA2) and 0.8992 g (transfected with annexin I-siRNA3), significantly lower (P < 0.001) than that of tumor from parent Suit-II cells (2.5866 g) and transfected with annexin I-siRNAN (2.4070 g). CONCLUSION: annexin I promotes the growth and proliferation of pancreatic carcinoma cells in vivo and increases the ability of tumor formation in nude mice. The results of this study support that annexin I may become a potential target in gene therapy for this disease.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
ANXA1Humanpancreatic cancer  IMP  RGD 
Anxa1Ratpancreatic cancer  ISOANXA1 (Homo sapiens) RGD 
Anxa1Mousepancreatic cancer  ISOANXA1 (Homo sapiens) RGD 

Objects Annotated

Genes (Rattus norvegicus)
Anxa1  (annexin A1)

Genes (Mus musculus)
Anxa1  (annexin A1)

Genes (Homo sapiens)
ANXA1  (annexin A1)


Additional Information